Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lunai Bioworks Inc. Director's Dealing 2021

Mar 12, 2021

34813_dirs_2021-03-11_e037f7f2-3957-4e75-a627-6f3aaf908365.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Enochian Biosciences Inc (ENOB)
CIK: 0001527728
Period of Report: 2021-03-06

Reporting Person: D An Evelyn (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-06 Option to Purchase Common Stock $3.77 A 19894 Acquired 2031-03-06 Common Stock (19894) Direct

Footnotes

F1: On March 6, 2021, Ms. D'An was granted an option to purchase 19,894 shares of common stock of Enochian Biosciences Inc., said option to vest on March 6, 2022.